In three patients.

The results of the patients with FLT3 – positive AML based on a cohort of patients in the ongoing Phase 1 trial of Ponatinib in haematological malignancies. Heavily pretreated patients with AML and a history of FLT3-ITD mutation was in this cohort after the recommended oral dose of Ponatinib identified in previous noted in previous cohorts. In three patients.received 45 mg per day Ponatinib.

About Acute Myeloid LeukemiaAcute myeloid leukemia is a cancer of of the bone marrow and blood. According to the American Cancer Society, an estimated 12,330 people were newly with AML in the U.S. In 2010 and an estimated 21,840 U.S. Deaths diagnosed with leukemia in 2010, 8950 is due to AML. The median age at diagnosis of AML is 67 years. From 1999 to 2006 , the five-year survival rate for AML was only 24 %.A wild sandstorms 365,250 years ago?Looking at the core sample dig five miles offshore from nearby will Ein Gedi, the researchers hope to locate particular date in the history the earth, the past of the planet condition. You will be capable be seen what the climate were 365,250 years forth, for example, and determine the years of a catastrophic earthquake.

Related Articles

Other Articles from "diagnostics":